Active, not recruitingPhase 2NCT06897748

A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils

Studying Holt-Oram syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AstraZeneca
Intervention
Placebo(drug)
Enrollment
98 target
Eligibility
40 years · All sexes
Timeline
2025 – 2026

Study locations (9)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06897748 on ClinicalTrials.gov

Other trials for Holt-Oram syndrome

Additional recruiting or active studies for the same condition.

See all trials for Holt-Oram syndrome →

← Back to all trials